Found: 43
Select item for more details and to access through your institution.
LRRK2 Loss‐of‐Function Variants: When Less Is More.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1754, doi. 10.1002/mds.28291
- By:
- Publication type:
- Article
Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle Factors.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1854, doi. 10.1002/mds.28238
- By:
- Publication type:
- Article
Blood Flow as a Route for Bidirectional Propagation of Synucleinopathy in Parkinson's Disease?
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1751, doi. 10.1002/mds.28236
- By:
- Publication type:
- Article
Debugging Adaptive Deep Brain Stimulation for Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Linking Huntington's Disease and X‐linked Dystonia Parkinsonism on the Molecular Level.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1752, doi. 10.1002/mds.28287
- By:
- Publication type:
- Article
Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Impact of the Coronavirus Disease 2019 Pandemic on Functional Movement Disorders: Lessons From a Specialized Clinic.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1723, doi. 10.1002/mds.28278
- By:
- Publication type:
- Article
Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Coronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1721, doi. 10.1002/mds.28277
- By:
- Publication type:
- Article
N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Neuropathological Findings in Ephedrone Encephalopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brief Clinical Rating Scales Should Not Be Overlooked.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reply to: "Spinal Cord Stimulation for Parkinson's Disease: Dynamic Habituation as a Mechanism of Failure?".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reply to: "Brief Clinical Rating Scales Should Not Be Overlooked".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reply to: "N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Spinal Cord Stimulation for Parkinson's Disease: Dynamic Habituation as a Mechanism of Failure?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Erratum to: "The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study", by Ray Chaudhuri et al. (Mov Disord 2020; 35: 116-133).
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish Patients.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1712, doi. 10.1002/mds.28261
- By:
- Publication type:
- Article
Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Holomedicine: Proof of the Concept of Interactive Three‐Dimensional Telemedicine.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1719, doi. 10.1002/mds.28249
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reply to: "Can the 2019 Novel Coronavirus Cause Parkinson's Disease?".
- Published in:
- 2020
- By:
- Publication type:
- Letter
If LRRK2 Set the Fire, Can Nonsteroidal Anti-inflammatory Drugs Wet the Flames?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Light and Shade in Patrick Lewis et al's Paper on the First Photographs of Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reply to: "Light and Shade in Patrick Lewis et al's Paper on the First Photographs of Parkinson's Disease".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Subclinical Cardiac Microdamage, Motor Severity, and Cognition in Parkinson's Disease.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1863, doi. 10.1002/mds.28129
- By:
- Publication type:
- Article
Movement Disorders: Volume 35, Number 10, October 2020.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1, doi. 10.1002/mds.27763
- Publication type:
- Article
Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1731, doi. 10.1002/mds.28215
- By:
- Publication type:
- Article
A Standardized MR Imaging Protocol for Parkinsonism.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1745, doi. 10.1002/mds.28204
- By:
- Publication type:
- Article
Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1755, doi. 10.1002/mds.28189
- By:
- Publication type:
- Article
Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1843, doi. 10.1002/mds.28190
- By:
- Publication type:
- Article
Synaptic Loss in Primary Tauopathies Revealed by [<sup>11</sup>C]UCB‐J Positron Emission Tomography.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1834, doi. 10.1002/mds.28188
- By:
- Publication type:
- Article
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1822, doi. 10.1002/mds.28186
- By:
- Publication type:
- Article
Dopamine D1 Receptors Regulate Spines in Striatal Direct‐Pathway and Indirect‐Pathway Neurons.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1810, doi. 10.1002/mds.28174
- By:
- Publication type:
- Article
Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1765, doi. 10.1002/mds.28173
- By:
- Publication type:
- Article
A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1802, doi. 10.1002/mds.28145
- By:
- Publication type:
- Article
MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1873, doi. 10.1002/mds.28143
- By:
- Publication type:
- Article
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT‐10).
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1796, doi. 10.1002/mds.28142
- By:
- Publication type:
- Article
Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1787, doi. 10.1002/mds.28141
- By:
- Publication type:
- Article
In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1774, doi. 10.1002/mds.28140
- By:
- Publication type:
- Article
A Gain‐of‐Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1868, doi. 10.1002/mds.28138
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1, doi. 10.1002/mds.27762
- Publication type:
- Article